Arkansas court tosses $1.2B judgment against J&J

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

LITTLE ROCK, Ark. (AP) _ The Arkansas Supreme Court has thrown out a $1.2 billion judgment against Johnson & Johnson in a lawsuit challenging its marketing of the antipsychotic drug Risperdal.

The Thursday ruling comes in an appeal of lawsuit filed by Arkansas against the drugmaker and subsidiary Janssen Pharmaceuticals. The state says the companies didn’t properly communicate the drug’s risks and marketed it for off-label use, calling the practices fraudulent.

Johnson & Johnson said there was no fraud and Arkansas’ Medicaid program wasn’t harmed.

The state Supreme Court ruled that the law the state sued under was improperly applied because it governs health care facilities, which the drug-maker isn’t.

Risperdal and similar antipsychotic drugs have been linked to increasd risk of strokes and death in elderly patients, along with seizures, weight gain and diabetes.

1 Comment

  • ByeByeToTheRite

    Wow, can you believe it? Our high courts sided with Rich Big Business again! That’s odd, ain’t it? Ha! LOL

    Seems the bigger the business, the more likely to get out of judgements against them. And legal drugs are a VERY BIG business! Billions, in fact, of money flushed down the toilet of drug maker’s profits.

    Sure glad they got that technicality worked out – this law only applies to the “little business” like a non-profit agency, but Giant Big Business J&J is not a “health care facility” per se. Man, those capitalist right-wing lawyers are clever, ya got to give ’em credit!

Comments are closed.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.